What Teranode does

Teranode, Inc. is a privately held enterprise software company that builds real-time drug safety and pharmacovigilance intelligence tools for the biopharmaceutical industry. Its flagship product, Teranode RTI (Real Time Intelligence), combines a Big Data analytics engine with a Business Process Automation platform to monitor adverse events, label changes, off-label use, and broader risk/benefit signals across an FDA-approved drug's lifecycle and the wider development pipeline. Target customers are bio-pharmaceutical companies (primary), with secondary reach into healthcare providers and payers/insurers who need timely drug safety and efficacy intelligence for clinical, coverage, and risk decisions.

The underlying technology is built on two pillars: a proprietary RAGE Linguistics Engine that uses computational linguistics and NLP to interpret unstructured text from internal documents, news, FDA filings, clinical trial data, and social media, guided by causal drug safety ontologies covering therapeutic effects, adverse events, and regulatory context; and the LiveBPA Platform licensed from Rage Frameworks Inc., which provides the business process automation and case management framework for integrating RTI insights into enterprise workflows. Supporting features include an integrated social media listening capability, heat-map/signal-detection visualizations, and integrations with industry-standard ontologies (SNOMED-CT, NCI Thesaurus, MedDRA) and document management systems (SharePoint, Documentum), with optional BI tooling via Spotfire and JasperReport.

Teranode operates an enterprise B2B go-to-market with consultative direct field sales, custom subscription-based pricing (annual cadence), and bespoke implementation and integration services. The company is small (11-50 employees), headquartered at Horwich in the United Kingdom, and shows limited signs of recent commercial activity: the public website still relies on Adobe Flash and carries a 2013 copyright, no funding rounds are disclosed after 2009, and no recent product launches or leadership changes are recorded in the available material. The overall posture suggests a niche specialist that may be operating in a maintenance or low-growth mode rather than an active scaling phase.

Name

Teranode

Legal name

Teranode, Inc.

Website

https://teranode.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Teranode is a privately held UK-based enterprise software firm that provides Teranode RTI, a Big Data and NLP-driven real-time drug safety intelligence platform combining a proprietary linguistics engine with business process automation, sold primarily to bio-pharmaceutical companies for pharmacovigilance and post-market safety monitoring.

Ownership category

akta.pro rank

Product category

Pharmaceutical Intelligence Software

akta.pro primary industry

Literature Monitoring & Social/Digital Media Safety Monitoring (HLAGALAL)

Keywords

• Pharmacovigilance analytics
• Drug safety intelligence
• Pharmaceutical data analytics
• Real-time adverse event monitoring
• Regulatory compliance software

Headquarters

HQ city

Horwich

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Enterprise Software Licensing: Teranode appears to operate as an enterprise software company offering its RTI platform to bio-pharmaceutical companies, healthcare providers, and payers/insurers. The platform requires integration into existing IT environments and includes case management capabilities, suggesting a combination of software licensing with implementation and professional services.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Teranode provides the Real Time Intelligence (RTI) platform, a Big Data analytics and Business Process Automation solution for pharmaceutical drug development and post-market safety monitoring. The platform combines the proprietary RAGE Linguistics Engine with causal drug safety ontologies to deliver real-time analysis of structured and unstructured data from internal and external sources, including social media, FDA documents, clinical trial data, and internal documents, generating cumulative real-time intelligence indices that reflect drug risk/benefit profiles.

Product overview

Teranode offers a unified product portfolio centered on the Teranode RTI (Real Time Intelligence) platform, a Big Data analytics solution combined with Business Process Automation for the pharmaceutical and healthcare industries. The flagship Teranode RTI product integrates the RAGE Linguistics Engine (a proprietary NLP/NLU technology) with the LiveBPA Platform from RAGE Frameworks to provide real-time drug safety monitoring and intelligence. Supporting features include a Social Media Listening Platform for tracking public sentiment and a Case Management Engine for alert escalation. Together, these components enable pharma companies to monitor adverse events, ensure regulatory compliance, and make informed decisions throughout the drug development lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• Teranode RTI (Real Time Intelligence)

Quantifiable outcome

• Automated analysis of thousands of public and premium sources in real time
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability6 records

Feature6 records

Partnerships

One partnership is on record.

• Rage Frameworks InccoreTechnology or IntegrationRage Frameworks Inc provides the underlying LiveBPA Platform technology that Teranode uses as the foundation for its RTI solution. This partnership enables Teranode to offer rapid integration into enterprise processes and systems. The LiveBPA Platform is described as purpose-built for enterprise-scale business transformation and is used by leading global corporations across multiple industries for aggregation and interpretation challenges in investment research, enterprise risk, supplier risk, and competitive intelligence.

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• Medidata Solutions (Dassault Systèmes): Medidata's clinical trial and safety platforms compete in adjacent life-sciences workflows to Teranode's, particularly around clinical-trial design and adverse-event data, though Medidata is much broader in scope across the clinical development lifecycle.
• Veeva Systems: Veeva's Vault Safety and Vault CTMS products serve pharma R&D and pharmacovigilance workflows. Like Teranode, Veeva focuses on life sciences, but at substantially larger scale with broader suite coverage including CRM and regulatory submissions.
• Evidera (PPD): Evidera provides real-world evidence, epidemiologic research, and payer-focused drug evidence services that overlap with Teranode's payer/insurer use cases around formulary decision-making and cost-benefit analysis.
• Sparta Systems (Honeywell): Sparta (now part of Honeywell) provides TrackWise quality management and, historically, pharmacovigilance-adjacent workflow tools for life sciences. The integration of safety and quality processes is comparable to Teranode's BPA-driven safety workflow approach.
• IQVIA: IQVIA offers safety and pharmacovigilance services alongside real-world evidence analytics for pharma. Its capabilities overlap with Teranode's payer-side drug risk/benefit intelligence and adverse-event analytics, though IQVIA operates at vastly larger scale.
• SAS Institute (Life Sciences Analytics): SAS provides advanced analytics, NLP, and AI for life sciences including pharmacovigilance and signal detection. Its text-analytics and AI capabilities overlap directly with Teranode's RAGE Linguistics Engine approach to unstructured drug-safety data.
• Oracle Health Sciences (Argus Safety): Oracle's pharmacovigilance suite (Argus Safety) is the most widely deployed adverse-event case-management platform in pharma. It overlaps directly with Teranode's safety-monitoring and case-management capabilities but addresses a broader enterprise life-sciences portfolio.

Direct peers

• Anju Software: Anju Software offers life-sciences applications including pharmacovigilance (TAOS), clinical trial management, and medical affairs — directly comparable to Teranode's drug-safety monitoring and analytics product set for mid-market and enterprise pharma.
• ArisGlobal: ArisGlobal's LifeSphere Safety platform offers pharmacovigilance case processing, signal detection, and regulatory reporting — directly competing with Teranode RTI's drug-safety monitoring and case management functionality for bio-pharma customers.

Others

• Cognizant Life Sciences: Cognizant provides pharmacovigilance services and technology implementations for pharma, including social-media and literature monitoring. It is comparable as a competitor for outsourced drug-safety intelligence, though its primary model is services rather than software licensing.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/teranode

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Teranode